ABSTRACT OBJECTIVES This study examined the effects of a cardiac rehabilitation (CR) program on functional capacity and health
destination therapy in which the device remains in use for the life of the patient (2) .
In addition to improved survival, some studies have shown improvements in functional capacity and health status (HS) following LVAD implantation (3, 4) . However, despite these improvements, many patients with LVADs continue to experience exercise intolerance and other heart failure (HF)-related symptoms (5, 6) . Leibner et al. (7) observed that cardiorespiratory fitness, as measured by peak oxygen uptake (VO 2 ), and ventilatory efficiency remained unchanged 1 year after LVAD implantation. Persisting functional limitations in this population can affect HF-related symptoms, HS, and, potentially, clinical outcomes (e.g., hospitalization) (8) . As the durability of LVADs improve and duration of support is extended, the assessment and optimization of functional capacity and HS become key components in the long-term management of these patients.
In patients with cardiovascular disease, cardiac rehabilitation (CR) improves survival, functional capacity, and quality of life (9) (10) (11) . Among patients with stable HF, exercise training improves peak VO 2 , reduces HF-related symptoms, and is associated with a lower risk for all-cause death or all-cause hospitalization (8, (11) (12) (13) (14) .
In contrast, there is little evidence that describes the effects of exercise training in patients with LVADs. Hayes et al. compared 8 weeks of homeversus facility-based exercise and found that cardiorespiratory fitness and quality of life improved in both groups (15) . Although the facility-based group showed a trend toward greater improvement, it did not reach statistical significance. The lack of statistical significance may have been due to the sample size (n ¼ 14).
The aim of the present study was to determine the impact of a 6-week CR exercise program on cardiorespiratory fitness, muscle strength, and HS in patients with a continuous-flow LVAD. We hypothesized that these parameters would be improved among LVAD patients who underwent supervised exercise training compared with a non-exercising control group.
METHODS AND STUDY DESIGN

Patients who underwent LVAD implantation between
June 2011 and September 2012 for any indication at Henry Ford Hospital were screened for participation.
Eligibility criteria included a recently implanted continuous-flow LVAD (i.e., 1 to 6 months from surgery date), age older than 18 years, and patients had to be free of any major comorbidities or limitations that might interfere with exercise training. Exclusion criteria included patients who declined to attend CR or who attended a CR program outside of the Henry Ford Health System. The protocol was reviewed and approved by the Henry Ford Health System Institutional Review Board, and all subjects provided written informed consent.
Following baseline testing, patients were randomized in a 2:1 fashion to either 6 weeks of CR or usual care (UC). Randomization was conducted using a computer random number generator, with group assignments transferred to allocation cards sealed in opaque sequential envelopes. Staff members who conducted the follow-up testing at 6 weeks after baseline were blinded to group assignment.
PATIENT TESTING
Before group assignment, all patients underwent initial testing that consisted of a self-reported patient HS questionnaire, a symptom-limited cardiopulmonary treadmill test (CPX), a 6-min walk (6MW) test, and a maximal single-leg isokinetic test to measure strength. The order of administrating these tests remained the same for all patients at both time points (i.e., at baseline and follow-up). Patient-reported HS was obtained using the Kansas City Cardiomyopathy Questionnaire (KCCQ), a 23-item questionnaire to evaluate patient responses across 5 domains (i.e., physical function, symptoms, social function, self-efficacy, and quality of life) (16) . The symptomlimited CPX test was then completed using the modified Naughton protocol (i.e., 1 metabolic equivalent increase per each 2-min stage). Expired air was sampled breath-by-breath and analyzed using a Medgraphics Ultima (Minneapolis, Minnesota) metabolic cart. Heart rate and blood pressure were measured in the supine and standing positions before exercise, at the end of each 2-min exercise stage, at peak exercise, and during recovery.
Gas exchange data were analyzed by a CPX core laboratory that was blinded to subject assignment.
Gas exchange data were reported using 20-s interval averages. Peak values were identified from the highest interval value during the final minute of exercise.
Ventilatory-derived anaerobic threshold was determined using the modified V-slope method by 3 independent reviewers. Minute ventilation to carbon dioxide slope was calculated using data from the cycle, arm ergometer, recumbent stepper) for a total of 30 min at a training intensity initially set at a heart rate corresponding to 60% of the heart rate reserve (difference between peak and heart rate at rest). Exercise training duration did not change throughout the program; however, staff encouraged patients to progress exercise intensity as tolerated up to 80% of the heart rate reserve.
USUAL CARE
Patients randomized into the UC group were not
given an individualized exercise prescription to follow or counseled about physical activity, but were told to continue to follow physician instructions regarding care, including the standard recommendation to perform daily walking. To partially control for patient contact, both UC and CR patients received follow-up calls at weeks 2, 4, and 6. The follow-up calls consisted of questions asking about new signs or symptoms, medications, hospitalizations, and any changes to activity levels.
OUTCOME MEASURES
The primary outcome was change in peak VO 2 . Secondary outcomes included: 1) KCCQ summary score;
2) peak torque from the single-leg extension isokinetic test; 3) 6MW distance; and 4) total treadmill time. Untoward clinical events were determined by a review of the electronic medical records (K.B.) and defined as any unexpected complication that resulted in an emergency department visit or hospitalization.
Any events outside of the hospital were confirmed during the patient follow-up calls. Scheduled hospitalizations (e.g., right heart catheterization) were not included as an untoward event.
FIGURE 1 Flow of Participants Through the Trial
LVAD ¼ left ventricular assist device.
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Cardiac Rehab Improves Function and KCCQ in LVADs 655 SUBANALYSIS. Within the 26 subjects who participated, a cohort of 7 male subjects had previous CPXs performed <6 months before LVAD implantation. We present these data to provide context and description of cardiorespiratory values before and following LVAD surgery.
STATISTICAL ANALYSIS
A paired t-test was used to assess within-group changes from baseline to 6 weeks. An independent sample t-test was used to compare the differences in change from baseline to follow-up between UC and CR patients. The Student's t-test and the chi-square test were used to compare groups at baseline for continuous and nominal data, respectively. Alpha level was set at 0.05 for all analyses. All statistical analyses were performed with IBM SPSS version 21.0 (Armonk, New York).
RESULTS
During the study, 26 of 39 eligible patients consented to participate. The flow of participants is shown in Figure 1 . The most common reason for nonparticipation was travel distance to the rehabilitation site.
Individuals who chose not to participate in the study (n ¼ 13) were similar across all reported demographic and clinical characteristics (e.g., ejection fraction, heart failure etiology, and so on) compared with the 26 who did undergo randomization, except for body mass index (27 kg/m 2 vs. 31 kg/m 2 ; p ¼ 0.025). Baseline characteristics of the study participants can be found in Table 1 .
Of the patients who were randomized into the CR group all but 1 completed 18 visits, with 84% completing all visits by week 6. The single patient in the intervention group who did not complete all 18 CR visits dropped out of the study due to relocation. All attempts to contact this patient for follow-up testing were unsuccessful. A second CR patient who finished all 18 visits was unable to complete follow-up testing due to acute cholecystitis, and shortly afterwards, a driveline infection that led to an extended hospital stay. In addition, 1 patient in the UC group had an extended hospital stay for an infection and also did not return for follow-up testing.
The CR group had a significant improvement (10%) in peak VO 2 from baseline to follow-up (p ¼ 0.007);
however, compared with the UC group, there were no difference in the change between groups (Table 2, Figure 2) . Similarly, the increase in 6MW distance was significant in the CR group only (p ¼ 0.001), but no significant difference was found compared with the control group ( Table 2) . The KCCQ summary score, leg strength, and total treadmill time all showed significant improvements both within the CR group and compared with the UC group ( Figures 3 and 4 , Table 2 ).
Other notable improvements observed only in the CR group included improvements in ventilatory-derived anaerobic threshold, heart rate during submaximal 
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exercise, and heart rate at minute one of recovery (Tables 2 and 3) .
Overall, the exercise sessions were well-tolerated and safe. Of the 313 total exercise visits, there was only 1 untoward event that required the patient to be transferred to the emergency department.
This was due to a syncopal episode immediately following the completion of an exercise session. Given the severe muscle atrophy and histochemical changes that occur in end-stage heart failure, the stimulus due to aerobic exercise might have been sufficient to improve leg strength. In patients with HF, aerobic exercise training improves skeletal muscle The change at follow-up was significant in the CR group (*p ¼ 0.003) and significantly different from changes in the usual care group ( †p ¼ 0.016). Abbreviation as in Figure 2 .
Cardiac Rehab Improves Function and KCCQ in LVADs perfusion, upregulates glycolytic enzymes, and decreases catabolic catalysts (e.g., interleukin-1, interleukin-6, tumor necrosis factor-alpha), all of which might have been associated with an observed increase in peak muscle strength in the CR group (20) .
The KCCQ score is a composite measure of patientreported symptoms and quality of life, and is associ- A clinically significant improvement (i.e., >1.0 ml/kg/min) in peak VO 2 was observed for the CR group. However, similar to findings from Hayes et al.,
we were unable to demonstrate a significant difference between the groups (15). Improvement in peak VO 2 , following LVAD implantation might simply be the result of improved hemodynamics, resulting in increased oxygen transport to skeletal muscles (3, 24) .
However, similar to the study by Leibner et al. (7), we found severe deconditioning that was persistent in most of our patients, with only 1 patient with a peak VO 2 at baseline >14 ml/kg/min.
In addition, in the 7 subjects who had a cardiorespiratory test before LVAD implantation, only 1 had an improved peak VO 2 following LVAD implantation (before training). The 6 other subjects had either no change or a decrease in cardiorespiratory fitness.
Despite improved circulatory support from the LVAD, the lack of improved exercise tolerance might have been due to the extended hospital stay following implantation (i.e., bed rest) and might partly explain why subjects in the UC group showed a trend toward improved fitness with the resumption of daily home physical activities.
Another contributing factor that might explain a lack of difference between groups in fitness was that the UC group had no restrictions regarding performing exercise on their own, and although it was not quantified, anecdotally, many UC subjects reported regular walking.
However, despite a lack of significant difference between groups for change in peak VO 2 , improvements in peak VO 2 , 6MW distance, treadmill time, ventilatory-derived anaerobic threshold, submaximal heart rate, and heart rate recovery were only HR ¼ heart rate; HRR ¼ heart rate recovery; MAP ¼ mean arterial pressure.
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